TherapeuticsMD, Inc. — Director's Dealing 2018

Mar 19, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2018-03-15

Reporting Person: Finizio Robert G (Director, CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-15	Non-Qualified Stock Option (right to buy)	$5.16	A	440000	Acquired	2028-03-15	Common Stock (440000)	Direct

Footnotes

F1: Underlying shares vest as follows: 146,667 shares on the first anniversary date of the grant, 146,667 shares on the second anniversary date of the grant, and 146,666 shares on the third anniversary date of the grant.